Results for "HDA Factbook"
Chip Davis Discusses HDA’s 2023 Priorities in Annual Chain Drug Review Column
With the welcoming of the new year and 118th Congress, HDA’s President and CEO Chip Davis penned an overview of the association’s 2023 priorities for the January 9 issue of Chain Drug Review.
Advocacy in Action: KeySource Capitalizes on Congressional Recess To Meet with Rep. Landsman
On August 25, HDA member KeySource hosted Congressman Greg Landsman (D-Ohio) and his staff at the company’s distribution center in Cincinnati, Ohio. KeySource CEO and HDA Board Member Albert Paonessa, III, and his team — including CFO Ryan Sevek, Fulfillment Vice President Thom Coleman, Sr. Vice President of Legal Affairs Robert Brown and Director of Fulfillment Stacy Ives — described KeySource’s role in the pharmaceutical supply chain as a national distributor of generic products to retail pharmacies, hospitals, clinics and other sites of care.
Chip Davis Shares HDA’s 2024 Policy Priorities in Annual Chain Drug Review Column
With a presidential election on the horizon and policymakers working to develop solutions to challenges facing patients and providers, HDA’s President and CEO Chip Davis provided key insights into the association’s 2024 policy priorities in his annual column, “Health Care Outlook,” by Chain Drug Review.